Osteopontin is a secreted, integrin-binding and phosphorylated acidic glycoprotein, which has an important role in tumour progression. We have shown that Wnt, Ets, AP-1, c-jun and b-catenin/Lef-1/Tcf-1 stimulates OPN transcription in rat mammary carcinoma cells by binding to a specific promoter sequence. However, co-repressors of OPN have not been identified. In this study, we have used the bacterial two-hybrid system to isolate cDNA-encoding proteins that bind to OPN and modulate its role in malignant transformation. Using this approach we isolated interferon-induced transmembrane protein 3 gene (IFITM3) as a potential protein partner. We show that IFITM3 and OPN interact in vitro and in vivo and that IFITM3 reduces osteopontin (OPN) mRNA expression, possibly by affecting OPN mRNA stability. Stable transfection of IFITM3 inhibits OPN, which mediates anchorage-independent growth, cell adhesion and cell invasion. Northern blot analysis revealed an inverse mRNA expression pattern of IFITM3 and OPN in human mammary cell lines. Inhibition of IFITM3 by antisense RNA promoted OPN protein expression, enhanced cell invasion by parental benign non-invasive Rama 37 cells, indicating that the two proteins interact functionally as well. We also identified an IFITM3 DNA-binding domain, which interacts with OPN, deletion of which abolished its inhibitive effect on OPN. This work has shown for the first time that IFITM3 physically interacts with OPN and reduces OPN mRNA expression, which mediates cell adhesion, cell invasion, colony formation in soft agar and metastasis in a rat model system.
Introduction
Osteopontin (OPN) is an extracellular matrix glycophosphoprotein that binds to alpha v-containing integrins (Denhardt and Guo, 1993) and has an important role in malignant transformation, malignant cell attachment and migration (Euer et al., 2002) . Stable transfection of benign, non-metastatic rat mammary cells with OPN cDNA endows the transfectants with the ability to metastasize in vivo (Oates et al., 1996) while OPN inhibition by antisense cDNA impedes cell growth and tumour-forming capacity (Behrend et al., 1994) . We and others have shown that OPN overexpression in human breast cancer is associated with early metastasis and poor outcome (Tuck et al., 1998; Rudland et al., 2000) and is also correlated with poor prognosis in gastric cancers (Ue et al., 1998) . OPN is predominantly secreted in tumours (Rittling et al., 2002) particularly in breast cancer, in which high plasma levels have been associated with metastasis (Singhal et al., 1997) . We have established a unique model of transformation of non-metastasizing breast cancer cells (Rama 37) to the metastatic phenotype, by transfection with tumour metastatic DNA. Short DNA sequences occur at a high frequency in breast cancer cells (Chen et al., 1997) . We have shown that stable transfection of benign mammary epithelium with these short DNA sequences (Met-DNA) promotes neoplastic transformation and metastasis (Chen et al., 1997) . These short DNA sequences sequester Tcf-4 and influence the expression of osteopontin (El-Tanani et al., 2001) . However, corepressors of OPN have not been identified.
To understand the physical basis of osteopontin downregulation in normal or benign cells, we have used the bacterial two-hybrid system (Green et al., 2007) to isolate cDNA-encoding proteins that bind specifically to OPN and modulate its role in malignant transformation. We show that interferon-induced transmembrane protein 3 gene (IFITM3) interacts with OPN, using bacterial and mammalian two-hybrid systems and co-immunoprecipitation experiments. Endogenous IFITM3 is expressed at low levels in human breast cancer cell lines and is highly expressed in normal and benign cell lines.
In this study, we show that IFITM3 significantly reduces OPN mRNA expression levels. Furthermore, we show that forced overexpression of IFITM3 in invasive Rama 37-OPN cells that have high constitutive OPN, inhibited OPN-mediated colony formation, cell adhesion and invasion in soft agar. In addition, inhibition of IFITM3 by antisense RNA in benign non-invasive Rama 37 cells promoted OPN protein expression and enhanced cell invasion. We have identified the IFITM3-binding domain that binds specifically to OPN by using the mammalian two-hybrid system. Deletion of this binding domain abolishes its ability to inhibit OPNmediated cell invasion and colony formation in soft agar.
Results
Isolation of cDNA coding for a protein that binds to osteopontin A commercial bacterial two-hybrid system (see Materials and methods section) was used to identify human cDNA-encoding proteins that bind to OPN. A cDNA library constructed from normal human breast tissues was inserted into the 'target' vector (Stratagene, Agilent Technologies UK Ltd, Stockport, Cheshire, UK), whereas cDNA coding for amino acids 1-317 of rat OPN, accession no. NM_012881 was inserted into the 'bait' vector. The two recombinant vectors were co-expressed in bacterial cells and approximately 10 9 bacterial transformants were screened. We identified one independent cDNA that potentiated activation of a Gal4-dependent reporter in the presence of the OPN-DBD fusion. Independent co-transformation of OPN and the candidate clone confirmed the interaction. The specificity was shown by lack of interaction with other control fusions, including pLamin C and murine p53, pSV40 ( Figure 1a) . Sequencing of the cDNA inserts of the isolated clone revealed that it encoded a full-length sequence of interferon-induced transmembrane protein 3 (accession no. NM_021034). This sequence encoded the entire protein (from amino acid residue 1-133).
Confirmation of IFITM3 and OPN interaction in vivo by a mammalian two-hybrid assay We confirmed and extended this result by examining the specificity of IFITM3 binding to OPN using an alternative version of the two-hybrid system in mammalian cells. Figure 1b presents S-14 kDa proteins corresponded to the major radioactive protein in the lysates and possessed the same molecular weight as reported for human IFITM3 (Rassart et al., 2000) . The specificity of the immunoprecipitated complexes formed between IFITM3 and OPN was then tested as follows. When 35 S-labeled IFITM3-containing lysates were incubated with unprogrammed non-radioactive lysates and then immunoprecipitated with anti-OPN, no radioactive IFITM3 protein of 14 kDa was observed on the resultant polyacrylamide gels (Figure 1c , lanes 4). This radioactive band was not observed in controls in which an unrelated transcription factor Tip 60-HA (Brady et al., 1999) (Figure 1c (Tanaka et al., 2004 (Tanaka et al., , 2005 . We transfected R37 cells with pBK-CMVTip 60 (Tip 60) (Brady et al., 1999) with or without IFITM3 to generate R37-Tip 60 and R37-Tip60-IFITM3 cells, respectively. Northern blot analysis using a cDNA fragment probe to Tip 60 showed no significant difference in Tip 60 mRNA expression between R37-Tip 60 and R37-Tip60-IFITM3 cells (data not shown). These results suggest that IFITM3 acts independently of the CMV promoter. Its effects on OPN under the control of the CMV promoter could involve effects on OPN mRNA stability or recruitment of unidentified OPN corepressors.
Effect of IFITM3 on proliferation, adhesion, invasion and anchorage-independent growth of OPN-transformed cells Proliferation of R37-OPN-IFITM3 cells was approximately 2.0-to 2.6-fold less than that of R37-OPN cells after 3 and 4 days, respectively (P ¼ 0.0003, P ¼ 0.0002) (Figure 2b 
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Effect of antisense IFITM3 on gene expression, proliferation and invasion of Rama 37 cells R37 cells were stably transfected with IFITM3 antisense (as-IFITM3) in an expression vector. Northern blot analysis using a cDNA fragment probe to IFITM3 and western blot analysis using a monoclonal antibody to OPN (see Materials and methods section) showed that IFITM3 mRNA levels were reduced by 80% (Figure 3a upper panel) and OPN protein level was increased by 90% in R37-as-IFITM3 cells compared with control R37 cells (Figure 3a , lower panel) (Po0.0001). Cell proliferation of R37-as-IFITM3 cells was 1.6-and 2-fold higher than that of R37 after 3 and 4 days, respectively (P ¼ 0.0001, P ¼ 0.0002) (Figure 3b ). R37-as-IFITM3 cells showed 1.7-fold greater invasion compared with R37 cells (Po0.0001) (Figure 3c ). These data suggest that antisense inhibition of IFITM3 converts the benign non-invasive Rama 37 cell phenotype to an invasive one.
Expression of OPN and IFITM3 in benign and malignant breast cells
We examined the expression of OPN and IFITM3 mRNAs in total RNA isolated from human benign and malignant breast cells by northern analysis. OPN mRNA was weakly expressed in all benign breast cells tested, whereas IFITM3 mRNA was highly expressed (Huma 7, Huma 109 and Huma 123) (Figure 4) . Conversely, high OPN and low IFITM3 mRNAs were observed in malignant breast cells (ZR-75, T47-D and MDA-MB 435s) (Figure 4) .
Analysis of the binding interface of IFITM3 using C-terminal serial deletion
To identify the regions of IFITM3 that interact strongly with OPN and regulate its expression, we generated serial C-terminal deletion constructs. We transiently transfected individual constructs together with PM-OPN, pVP16-IFITM3-D1, D2 or D3 (Figure 5a ) and pG5-CAT reporter plasmid (Jin et al., 2006; Green et al., 2007) into parental R37 cells. The pSV40-bgalactosidase construct was used in all transfections as an internal control. The deletion construct IFITM3-D3, which encoded the amino acid sequence 60-93 (Figures 5a and b) stimulated the pG5-CAT promoter activity. However, neither IFITM3-D1 nor IFITM3-D2 constructs stimulated CAT promoter activity. The region of amino acid 60-93 within IFITM3-D3 stimulated the pG5-CAT promoter by 90% of that of the full-length IFITM3, but IFITM3-D1 and D2 with amino acid 60-93 sequence deleted were ineffectual (Figure 5b) .
Colony formation and cell invasion of R37-OPN cells were increased over parental R37 cells; (Figures 5b  and c ; Po0.001). Stable transfection of R37-OPN cells with IFITM3-D3 in an expression vector (R37-OPN-IFITM3-D3 cells) reduced colony formation and cell invasion to similar levels observed in parental R37 cells (Figures 5c and d ; Po0.001). In contrast, R37-OPN-IFITM3-D1 or R37-OPN-IFITM3-D2 cells showed no significant differences in colony formation from R37-OPN cells. These results suggest that amino acid region 60-93 of the IFITM3 protein is important in the IFITM3-OPN interaction and consequent biological effect.
Discussion
Osteopontin (OPN) is a multifunctional protein implicated in mammary metastasis (Oates et al., 1996) and prognosis of breast cancer . We used the bacterial two-hybrid system (Real et al., 2006) to isolate cDNA-encoding proteins that bind to OPN and modulate its role in malignant transformation. Using this approach we observed an interaction between osteopontin and interferon-induced transmembrane protein 3 (IFITM3). This interaction was confirmed in a mammalian model, using the mammalian two-hybrid system and by co-immunoprecipitation assays. By screening a lymphoid cell cosmid library with a probe corresponding to the 3 0 -untranslated region of IFITM1, Lewin et al. (1991) isolated cosmids containing the IFITM1, IFITM2 and IFITM3 genes, which they termed 9-27, 1-8D and IFITM3, respectively. Interferons have critical roles in tumour surveillance by effects on apoptosis and through anti-proliferative and differentiating activities (Yang et al., 2005a, b) . They also have major roles in cellular defence against viral and parasitic infection (Yang et al., 2005a, b) . Interferon target genes include the interferon-inducible transmembrane protein (IFITM) family genes, which comprise of IFITM1 (9-27), IFITM2 and IFITM3 (Lewin et al., 1991; Lange et al., 2003) . These genes have been implicated in several cellular processes such as homotypic cell adhesion functions of interferon and cellular anti-proliferative activities (Evans et al., 1993; Andreu et al., 2006) . Analysis of the functional role of IFITM3 in OPN activation/inhibition was investigated by overexpressing the gene in cells co-transfected with OPN. The benign R37 rat mammary cell line stably transfected with an expression vector for OPN, termed R37-OPN cells increased OPN mRNA and protein levels . Overexpression of IFITM3 in OPN-transfected R37 cells causes a reduction in the level of OPN mRNA. This suggests that IFITM3 acts at the level of OPN transcription. The mechanism may involve either inhibition of transcription by recruitment of corepressors, inhibition of coactivators or effects on OPN mRNA stability. A precedent for this last mechanism has been reported by Zhang et al. (2009) who showed that elongation translation factor-1A1 (EF1A1), a transacting protein, regulates OPN mRNA stability (Zhang et al., 2009) . In this study, we suggest that IFITM3 may act similarly in the regulation of OPN mRNA stability. This is the subject of ongoing investigation in our lab. In this study, we showed that IFITM3 had an inhibitory effect on OPN production and function in R37-OPN cells. These results were not an artefact of a single clone of transformed cells, Effect of permanent transfection of expression vectors for as-IFITM3 on cell invasion of on Rama 37 (R37) and R37-as-IFITM3 transformed subclones: R37 and R37-as-IFITM3 cells were tested; the abbreviations used as described in Materials and methods. Cells were cultured in Boyden chambers using fibronectin in the lower chamber as a chemoattractant. Cells that invaded through the dividing membrane were fixed, stained, the stain released with 10% (v/v) acetic acid and the resultant absorbance was measured at 650 nm (Materials and methods). Results shown represent the mean±s.d. of three experiments.
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expression patterns of IFITM3 and OPN mRNA in human benign and malignant mammary cell lines. Previous studies have shown that increased level of IFITM3 is accompanied by decreased cell proliferation in several cancer cell lines and IFITM3 is often repressed in the course of malignant transformation and tumour development (Brem et al., 2003) . Conversely, increased tumour cell proliferation may be associated with decreases in IFITM3 expression levels in cancer patients (Brem et al., 2003) . Brem et al. (2003) have also shown that Ras-mediated transformation of mouse mast cells is associated with downregulation of IFITM3 expression and interferon-a treatment reverts the proliferation rate to the level found in normal levels together with induction of IFITM3 (Brem et al., 2003) . Our data have also shown that overexpression of OPN inhibited apoptosis and IFITM3 blocked this effect (Figure 2f) . These results are consistent with the studies showing that the addition of soluble OPN-protected cells against serum starvation-mediated apoptosis in two-dimensional (Khan et al., 2002) and three-dimensional cultures (Geissinger et al., 2002) . Furthermore, exogenous OPN decreased apoptotic cell death from oxygen and glucose deprivation. (Meller et al., 2005) . It has also been shown that OPN-deficient mice have higher TUNEL staining and less papilloma development when treated with chemical carcinogen (Hsieh et al., 2006) . Furthermore, permanent transfection of IFITM3 antisense cDNA (as-IFITM3) in an expression vector into R37 cells led to an elevated level of OPN mRNA and protein expressions and conferred the ability to increase cell invasion.
Interferons have important influences on apoptosis, proliferation and differentiation (Yang et al., 2005a, b) . Nicolini et al. (2006) showed that low levels of interferon were associated with a poorer prognosis in breast cancer patients. The overexpression of interferon (Nicolini et al., 2006) may reflect selection in some tumours for those cells capable of mounting a co-ordinated response to decrease the levels of proteins important for successful development of the cancer metastasis. In breast cancer cells IFITM3 could promote cell differentiation and growth arrest and this may partly explain its proposed role in tumourigenesis (Andreu et al., 2006) . In addition to determining the functional role of IFITM3, we also identified the cognate IFITM3 domain for specific OPN binding and showed that deletion of this domain abolished its ability to inhibit OPN, which mediated cell invasion and colony formation in soft agar. These results suggest that IFITM3 can reverse the invasive cell phenotype in vitro and that it has a key role in OPN regulation.
In conclusion this study shows that IFITM3 reduces OPN mRNA and OPN-mediated malignant transformation of mammary epithelium. We have also shown that inhibition of IFITM3 mRNA expression by antisense cDNA induces an invasive phenotype. Our results suggest that IFITM3 can regulate a major effector molecule (OPN) that regulates the invasive phenotype in breast cancer. The identification of such effector molecules is of fundamental importance in piecing together cellular regulatory networks and may help to identify novel targets for anticancer therapies. 
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Materials and methods

Cell lines and cell culture
The rat mammary (Rama 37) non-metastatic benign tumourderived cell line (Dunnington et al., 1983) , derivative stablytransformed cell subclones, ZR-75, MDA-MB-435s, Huma 7, Huma 109 and Huma 123 cell lines (El-Tanani et al., 2004) were cultured in Dulbecco's modified Eagle's medium, 10% (v/v) fetal calf serum, 100 mg/ml penicillin, 100 mg/ml streptomycin were cultured in Dulbecco's modified Eagle's medium (DMEM), 10% (v/v) fetal calf serum, 100 mg/ml penicillin, 100 mg/ml streptomycin (Invitrogen, Paisley, Scotland, UK) .
Chemicals and materials
Tissue culture medium, newborn calf serum, fetal calf serum, antibiotics and trypsin-EDTA were purchased from GIBCO BRL (Paisley, Scotland). Restriction enzymes, DNA modifying enzymes and Taq polymerase were obtained from Boehringer Mannheim (Lewes, England). Construction and screening of the cDNA library The BacterioMatch Two-Hybrid assays (Stratagene) were used according to the manufacturer's instructions, to screen a Premade BacterioMatch II Human Breast Library (cat no. 982215). The cDNA was directionally inserted into EcoR1/ Xho1-digested BacterioMatch pTRG XR vector. Rat OPN (coding for amino acids 1-317) was prepared by PCR amplification from plasmid pBK-CMV DNA. OPN cDNA was inserted into the XhoI site of the pBT vector and the correct orientation and insertion of the DNA was confirmed by determining the nucleotide sequence of the recombinant vector, across the XhoI site. After cotransformation of BacterioMatch two-hybrid reporter strain competent cells XL-1Blue MRF 0 Kan cell with the two vectors, cells were selected for growth in medium with kanamycin (50 mg/ml), tetracycline (12.5 mg/ml), chloramphenicol (34 mg/ml) (activation of HIS-3 conferring the ability to grow on media containing 3-AT, aadA, encoding a protein that confers streptomycin resistance reporter genes and lac promoter indicating cDNAencoded protein binding to the hybrid 'bait' protein). From approximately 10 9 transformed bacterial cells, 85 were selected in this manner. These were then assayed for their expression of the b-galactosidase reporter gene-the production of blue colouration with X-gal substrate indicating a positive result.
Expression vectors and reporter constructs
Quantitative assay for b-galactosidase The p53 (DNA coding for amino acids 72-390 of murine p53 within pBDGAL4 vector), pLamin C (DNA coding for amino acids 67-230 of human lamin C within pBDGAL4) and pSV40 (DNA coding for amino acids 84-708 of the SV40 large T-antigen within pADGAL4 vector) control plasmids were obtained from Stratagene as components of the BacterioMatch Two-Hybrid assays. The quantitative liquid b-galactosidase assay was conducted according to protocol 10 of Becker & Fikes (Olesen et al., 1991) .
Determination of binding specificity in vivo by mammalian two-hybrid system The positive control plasmids, pM-53 (a fusion of GAL4 DNA-binding domain to murine p53) and pVP16-T (a fusion of GAL4-activating domain to SV40 large T antigen, which interacts with p53), were components of the Mammalian MATCHMAKER two-hybrid kit. DNA coding for the complete OPN cDNA was amplified by PCR of pBK-CMV using primers that incorporated EcoR1 (5 0 primer) and Sal1 (3 0 primer) sites. The amplified product was digested with EcoR1 and Sal1 and ligated to plasmid pM, digested with the same restriction enzymes. In the same manner, the sequence coding for full-length IFITM3 was amplified by PCR of plasmid pTRG XR and inserted into EcoR1/Sal1 digested pVP16. R37 cells were cotransfected with combinations of bait (OPN) and target plasmid (IFITM3), the CAT reporter plasmid pG5CAT and pSV-b-galactosidase plasmid (Promega, Madison, USA) as previously described (Green et al., 2007) . Cells were cultured for 48 h and then harvested and CAT (liquid scintillation method) and b-galactosidase activities were assayed in whole cell extracts using assay kits (Promega) according to the manufacturer's protocols. CAT activity results were normalized relative to the b-galactosidase activity and are expressed as a percentage of the positive control level (pM-53 þ pVP16T). Results are the mean ± s.d. of at least three separate experiments.
In vitro binding assay complex detection by coimmunoprecipitation For immunoprecipitation in vitro, products were generated in a coupled transcription-translation cell-free protein-synthesizing reticulocyte lysate with [
35 S] methionine and the expression vector for IFITM3 or non-radioactive amino acids and expression vectors for OPN, Tip 60-HA, unprogrammed lysate for the empty vector pCMV-HA and immunoprecipitated with MAbs to OPN, as well as HA antibody as described previously . Characterization of the MAbs to OPN has been undertaken previously . The rabbit polyclonal antibody to HA-tag raised against an internal region of the influenza hemagulatinin (HA) protein (sc-805) also produced the correct-sized proteins on western blots (Santa Cruz Biotech) . In detail, cDNA templates for OPN and IFITM3 were prepared using a Qiagen kit (Qiagen House, West Sussex, UK) and resuspended in RNase-free distilled water. An in vitro coupled transcription and translation kit (T7/T3-TNT; Promega, Madison, WI, USA) was used according to the manufacturer's instructions. After completion of the 90-min reaction, samples were kept on ice. One ml of immunoprecipitation buffer (50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.2 mM Na 3 VO 4 , 0.5% (w/v) Nonidet P-40, 1 mM phenylmethylsulfonyl fluoride, 1 mM dithiothreitol, 25 mg/ml leupeptin, 25 mg/ml aprotinin and 25 mg/ml pepstatin) were added to each sample, mixed and incubated on ice for 30 min. Twenty microlitres of protein A/G-agarose (PAGA), pre-washed three times in immunoprecipitation buffer, were added to each sample and incubated for an additional 4 h at 4 1C with rotation to remove any proteins that had interacted non-specifically with PAGA. PAGA was removed by centrifugation at 14 000 r.p.m. for 3 min in a bench-top centrifuge. The supernatant containing [ 35 S] IFITM3 was mixed, in turn with supernatants containing one of non-radioactive OPN and the combined supernatants were then incubated with 2.5 mg of the requisite antibody overnight at 4 1C with rotation. Twenty microlitres of PAGA were added to each sample and incubated at 4 1C for an additional 60 min. PAGA antibody conjugates were recovered by centrifugation at 14 000 r.p.m. for 3 min, resuspended in 1 ml of Buffer A (phosphate-buffered saline, 0.2% (w/v) Triton X-100 and 350 mM NaCl), and recentrifuged. Samples were resuspended in 1 ml of Buffer B (phosphate-buffered saline, 0.2% (w/v) Triton X-100), centrifuged, and resuspended in SDS sample buffer. Samples were resolved by electrophoresis on 10% (w/v) polyacrylamide gels at 200 V for 45 min with equal amounts of protein being loaded per lane. The gel was fixed for 30 min in 10% (v/v) propanol, 10% (v/v) acetic acid, dried under vacuum and exposed to Kodak X-Omat AR X-ray film for 6-24 h before developing the film as we have previously described .
Plasmids and oligonucleotides
The expression vectors for rat OPN, OPN-pBK-CMV (16) and for human IFITM3 were prepared as described previously (Liu et al., 2002) ; those for antisense to IFITM3 RNA, antisense-IFITM3-pcDNA4 were prepared as described below. DNA sequencing confirmed their authenticity. To construct antisense IFITM3 cDNA, IFITM3 cDNA was cloned in an antisense (as) orientation into the EcoR1 and Xba1 site of pcDNA4, downstream of the T3 and T7 RNA polymerase promoters as we have previously described . This expression vector was termed as-IFITM3.
Serial deletion of IFITM3 cDNA A series of deletion constructs at the 3 0 end of IFITM3 gene were generated to map the binding domain, which binds with OPN protein. Primers were designed approximately every 100 bp along the length of the IFITM3 3 0 end and were used to amplify a series of truncated 'target' constructs termed IFITM3-D1 (nucleotides 1-230 (1-50 a.a.(amino acid)) ), IFITM3-D2 (nucleotides 1-347 (1-90 a.a.)), IFITM3-D3 (nucleotides 1-450 (1-124 a.a.)), IFITM3-D4 (nucleotides 1-566 (1-163 a.a.)) (Figure 5a ). EcoRI and XhoI restriction sites were incorporated into the respective primers to facilitate subcloning into the pcDNA6/HisC vector and pVP16 vector. The primer sequences are:
Forward All 4 constructs were initially PCR amplified using the appropriate primer pairs, cloned in the above expression vectors and the DNA corresponding to each construct was confirmed by sequencing.
Production of stable transformant cell lines R37 and derivative cell lines were cultured as outlined above. Cells were harvested and seeded in multi-well plates at 2.5 Â 10 5 /3.5 cm diameter well in 1 ml of serum-free medium. Initially, R37 cells were transfected with expression vectors for OPN, IFITM3 or with both expression vectors for OPN and IFITM3 as previously described (El-Tanani et al., 2006) using 1.0 mg/ml geneticin (Invitrogen) for OPN or 5 mg/ml blasticidin (Invitrogen) for IFITM3 transfections as the selective medium to generate R37-OPN, R37-IFITM3 and R37-OPN-IFITM3 cell lines, respectively. The as-IFITM3 construct was transfected separately into R37 cell line, and these were stably selected using 250 mg/ml Zeocin (El-Tanani et al., 2006); they were termed R37/as-IFITM3 cell line. Single-cell clones from each of the above transfectants were pooled and collected under selective pressure to provide multi-clonal cell lines for each of the above transfectants, 5 single-cell clones were also retained. Results were shown for the pooled transformant cell clones, those for single-cell cloned cell lines were substantially the same (not shown).
